NASDAQ$ZIMV
ZimVie Inc · Q4 2024 earnings
Q4 2024 earnings · · After market close · Investor relations
Briefing
ZimVie reported its fourth quarter and full year 2024 financial results, showing a decrease in net sales but an improvement in net loss and adjusted EBITDA.
ZimVie reported fourth quarter 2024 net sales of $111.5 million, a 1.4% decrease from the previous year. Despite this, the company significantly improved its net loss, reducing it to $(9.7) million from $(22.2) million in Q4 2023, and saw an increase in adjusted EBITDA to $18.4 million.
- Fourth quarter 2024 net sales were $111.5 million, a decrease of 1.4% on a reported basis compared to Q4 2023.
- Net loss for Q4 2024 improved significantly to $(9.7) million from $(22.2) million in Q4 2023.
- Adjusted EBITDA for Q4 2024 increased to $18.4 million, up from $13.9 million in Q4 2023.
- Diluted EPS for Q4 2024 was $(0.35), while adjusted diluted EPS was $0.27.
Headline financials
Revenue & EPS history
ZimVie · Revenue · Quarterly
$112M
Forward guidance
For the full year 2025, ZimVie projects net sales between $445 million and $460 million, representing a flat to 3% growth in constant currency. Adjusted EBITDA is expected to be between $65 million and $70 million, an 8% to 17% increase, and adjusted EPS is projected to be between $0.80 and $0.95, a 31% to 55% increase.
Tailwinds
- Projected constant currency net sales growth of Flat to 3%.
- Anticipated Adjusted EBITDA growth of 8% to 17%.
- Expected Adjusted EPS growth of 31% to 55%.
- Continued optimism about long-term drivers of the dental implant market.
- Well-positioned to take advantage of growth in dental implant and digital solutions market.
Headwinds
- Net sales projected to be between (1%) to 2% on a reported basis, indicating potential slight decline.
- No specific negative factors were highlighted in the forward guidance section.
- The guidance does not provide a detailed breakdown of potential challenges.
- Reliance on continued success of training and education programs.
- Market conditions could impact actual results.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 6 quarterly earnings reports · overlaid with Q4 2024
-1.7%
Avg return
Earnings day
-3.4%
Avg return
5 days after
-5.3%
Avg return
30 days after
44%
8 / 18 earnings
Positive
+24.0%
Q1 2023
Best reaction
-49.0%
Q4 2022
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q3 2025 | — | — | — | |
| Q2 2025 | -0.4% | -0.1% | +0.1% | |
| Q1 2025 | -4.4% | -4.8% | +2.2% | |
| Q4 2024 | -1.7% | +3.1% | -11.9% | |
| Q3 2024 | +0.6% | +5.5% | +6.2% | |
| Q2 2024 | -18.2% | -19.0% | -17.9% | |
| Q1 2024 | +5.7% | +4.8% | +0.8% | |
| Q4 2023 | -14.4% | -13.4% | -16.9% | |
| Q3 2023 | +5.4% | — | — | |
| Q2 2023 | -6.0% | — | — | |
| Q1 2023 | +24.0% | — | — | |
| Q4 2022 | -49.0% | — | — | |
| Q3 2021 | +20.0% | — | — | |
| Q3 2022 | +20.0% | — | — | |
| Q2 2021 | -8.2% | — | — | |
| Q2 2022 | -8.2% | — | — | |
| Q1 2021 | -6.5% | — | — | |
| Q4 2021 | +5.1% | — | — | |
| Q4 2020 | +5.1% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro